Aptorum Group shares surge 64.95% intraday after announcing an all-stock merger with DiamiR Biosciences.

Wednesday, Jul 16, 2025 9:45 am ET1min read
APM--
Aptorum Group Limited rose 64.95% in intraday trading, following the announcement of a definitive agreement for an all-stock merger transaction with DiamiR Biosciences. The merger will see DiamiR Biosciences become a wholly-owned subsidiary of Aptorum Group, which is expected to enhance the company's capabilities in developing innovative blood-based tests for brain health and other diseases.

Aptorum Group shares surge 64.95% intraday after announcing an all-stock merger with DiamiR Biosciences.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet